{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T14:10:32Z","timestamp":1777299032193,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,7,10]],"date-time":"2015-07-10T00:00:00Z","timestamp":1436486400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1038\/eye.2015.125","type":"journal-article","created":{"date-parts":[[2015,7,10]],"date-time":"2015-07-10T09:31:28Z","timestamp":1436520688000},"page":"1204-1212","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sj\u00f6gren\u2019s syndrome"],"prefix":"10.1038","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4839-3416","authenticated-orcid":false,"given":"N","family":"Yokoi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Sonomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Komuro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,10]]},"reference":[{"key":"BFeye2015125_CR1","doi-asserted-by":"crossref","unstructured":"The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye Work Shop. Ocul Surf 2007; 5: 75\u201392.","DOI":"10.1016\/S1542-0124(12)70081-2"},{"key":"BFeye2015125_CR2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","volume":"366","author":"RI Fox","year":"2005","unstructured":"Fox RI . Sj\u00f6gren's syndrome. Lancet 2005; 366: 321\u2013331.","journal-title":"Lancet"},{"key":"BFeye2015125_CR3","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/00003226-199405000-00002","volume":"13","author":"K Tsubota","year":"1994","unstructured":"Tsubota K, Toda I, Yagi Y, Ogawa Y, Ono M, Yoshino K . Three different types of dry eye syndrome. Cornea 1994; 13: 202\u2013209.","journal-title":"Cornea"},{"key":"BFeye2015125_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0014-4835(03)00087-3","volume":"77","author":"S Kawasaki","year":"2003","unstructured":"Kawasaki S, Kawamoto S, Yokoi N, Connon C, Minesaki Y, Kinoshita S et al. Up-regulated gene expression in the conjunctival epithelium of patients with Sj\u00f6gren's syndrome. Exp Eye Res 2003; 77: 17\u201326.","journal-title":"Exp Eye Res"},{"key":"BFeye2015125_CR5","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S1542-0124(12)70148-9","volume":"2","author":"ME Stern","year":"2004","unstructured":"Stern ME, Pflugfelder SC . Inflammation in dry eye. Ocul Surf 2004; 2: 124\u2013130.","journal-title":"Ocul Surf"},{"key":"BFeye2015125_CR6","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.exer.2005.07.009","volume":"82","author":"N Hirai","year":"2006","unstructured":"Hirai N, Kawasaki S, Tanioka H, Connon CJ, Yamasaki K, Yokoi N et al. Pathological keratinisation in the conjunctival epithelium of Sj\u00f6gren's syndrome. Exp Eye Res 2006; 82: 371\u2013378.","journal-title":"Exp Eye Res"},{"key":"BFeye2015125_CR7","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1167\/iovs.09-4188","volume":"51","author":"B Caffery","year":"2010","unstructured":"Caffery B, Simpson T, Wang S, Bailey D, McComb J, Rutka J et al. Rose bengal staining of the temporal conjunctiva differentiates Sj\u00f6gren's syndrome from keratoconjunctivitis sicca. Invest Ophthalmol Vis Sci 2010; 51: 2381\u20132387.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye2015125_CR8","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0161-6420(97)30330-3","volume":"104","author":"SC Pflugfelder","year":"1997","unstructured":"Pflugfelder SC, Tseng SC, Yoshino K, Monory D, Felex C, Reis BL . Correlation of goblet cell density and mucosal epithelial membrane mucin expression with rose bengal staining in patients with ocular irritation. Ophthalmology 1997; 104: 223\u2013235.","journal-title":"Ophthalmology"},{"key":"BFeye2015125_CR9","first-page":"1004","volume":"43","author":"P Arg\u00fceso","year":"2002","unstructured":"Arg\u00fceso P, Balaram M, Spurr-Michaud S, Keutmann HT, Dana RM, Gipson IK . Decreased levels of the goblet cell mucin MUC5AC in tears of patients with Sj\u00f6gren\u2019s syndrome. Invest Ophthalmol Vis Sci 2002; 43: 1004\u20131011.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye2015125_CR10","first-page":"96","volume":"42","author":"T Fujihara","year":"2001","unstructured":"Fujihara T, Murakami T, Fujita H, Nakamura M, Nakata K . Improvement of corneal barrier function by the P2Y2 agonist INS365 in a rat dry eye model. Invest Ophthalmol Vis Sci 2001; 42: 96\u2013100.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Pt A","key":"BFeye2015125_CR11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/978-1-4615-0717-8_36","volume":"506","author":"BR Yerxa","year":"2002","unstructured":"Yerxa BR, Douglass JG, Elena PP, Caillaud T, Amar T, Edick C et al. Potency and duration of action of synthetic P2Y2 receptor agonists on Schirmer scores in rabbits. Adv Exp Med Biol 2002; 506 (Pt A): 261\u2013265.","journal-title":"Adv Exp Med Biol"},{"key":"BFeye2015125_CR12","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1159\/000067042","volume":"34","author":"T Murakami","year":"2002","unstructured":"Murakami T, Fujita H, Fujihara T, Nakamura M, Nakata K . Novel noninvasive sensitive determination of tear volume changes in normal cats. Ophthalmic Res 2002; 34: 371\u2013374.","journal-title":"Ophthalmic Res"},{"key":"BFeye2015125_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ajo.2013.09.009","volume":"157","author":"N Yokoi","year":"2014","unstructured":"Yokoi N, Kato H, Kinoshita S . Facilitation of tear fluid secretion by 3% diquafosol ophthalmic solution in normal human eyes. Am J Ophthalmol 2014; 157: 85\u201392.","journal-title":"Am J Ophthalmol"},{"key":"BFeye2015125_CR14","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1089\/10807680260218524","volume":"18","author":"T Fujihara","year":"2002","unstructured":"Fujihara T, Murakami T, Nagano T, Nakamura M, Nakata K . INS365 suppresses loss of corneal epithelial integrity by secretion of mucin-like glycoprotein in a rabbit short-term dry eye model. J Ocul Pharmacol Ther 2002; 18: 363\u2013370.","journal-title":"J Ocul Pharmacol Ther"},{"key":"BFeye2015125_CR15","first-page":"261","volume":"28","author":"Y Takaoka-Shichijo","year":"2011","unstructured":"Takaoka-Shichijo Y, Sakamoto A, Nakamura M . Effect of diquafosol tetrasodium on MUC5AC secretion by rabbit conjunctival tissues. J Eye 2011; 28: 261\u2013265.","journal-title":"J Eye"},{"key":"BFeye2015125_CR16","first-page":"425","volume":"28","author":"Y Takaoka-Shichijyo","year":"2011","unstructured":"Takaoka-Shichijyo Y, Nakamura M . Stimulatory effect of diquafosol tetrasodium on the expression of membrane-binding mucin genes in cultured human corneal epithelial cells. J Eye 2011; 28: 425\u2013429.","journal-title":"J Eye"},{"key":"BFeye2015125_CR17","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s12325-012-0033-9","volume":"29","author":"M Nakamura","year":"2012","unstructured":"Nakamura M, Imanaka T, Sakamoto A . Diquafosol ophthalmic solution for dry eye treatment. Adv Ther 2012; 29: 579\u2013589.","journal-title":"Adv Ther"},{"key":"BFeye2015125_CR18","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1016\/j.ophtha.2012.04.010","volume":"119","author":"Y Matsumoto","year":"2012","unstructured":"Matsumoto Y, Ohashi Y, Watanabe H, Tsubota K, Diquafosol Ophthalmic Solution Phase 2 Study Group. Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: A Japanese phase 2 clinical trial. Ophthalmology 2012; 119: 1954\u20131960.","journal-title":"Ophthalmology"},{"key":"BFeye2015125_CR19","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1136\/bjophthalmol-2011-301448","volume":"96","author":"E Takamura","year":"2012","unstructured":"Takamura E, Tsubota K, Watanabe H, Ohashi Y, Diquafosol Ophthalmic Solution Phase 3 Study Group. A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients. Br J Ophthalmol 2012; 96: 1310\u20131315.","journal-title":"Br J Ophthalmol"},{"key":"BFeye2015125_CR20","first-page":"527","volume":"29","author":"M Yamaguchi","year":"2012","unstructured":"Yamaguchi M, Tsubota K, Watanabe H, Ohashi Y . The safety and efficacy of long-term treatment with 3% diquafosol ophthalmic solution for dry eye. J Eye 2012; 29: 527\u2013535.","journal-title":"J Eye"},{"key":"BFeye2015125_CR21","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s12325-014-0162-4","volume":"31","author":"M Yamaguchi","year":"2014","unstructured":"Yamaguchi M, Nishijima T, Shimazaki J, Takamura E, Yokoi N, Wantanbe H et al. Clinical usefulness of diquafosol for real-world dry eye patients: a prospective, open label, non-interventional, observational study. Adv Ther 2014; 31: 1169\u20131181.","journal-title":"Adv Ther"},{"key":"BFeye2015125_CR22","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s10384-013-0251-y","volume":"57","author":"S Koh","year":"2013","unstructured":"Koh S, Ikeda C, Takai Y, Watanabe H, Maeda N, Nishida K . Long-term results of treatment with diquafosol ophthalmic solution for aqueous-deficient dry eye. Jpn J Ophthalmol 2013; 57: 440\u2013446.","journal-title":"Jpn J Ophthalmol"},{"key":"BFeye2015125_CR23","doi-asserted-by":"publisher","first-page":"C595","DOI":"10.1152\/ajpcell.2001.281.2.C595","volume":"281","author":"Y Li","year":"2001","unstructured":"Li Y, Kuang K, Yerxa B, Wen Q, Rosskothen H, Fischbarg J . Rabbit conjunctival epithelium transports fluid, and P2Y2 receptor agonists stimulate Cl- and fluid secretion. Am J Physiol Cell Physiol 2001; 281: C595\u2013C602.","journal-title":"Am J Physiol Cell Physiol"},{"key":"BFeye2015125_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000076887","volume":"36","author":"T Murakami","year":"2004","unstructured":"Murakami T, Fujihara T, Horibe Y, Nakamura M . Diquafosol elicits increases in net Cl- transport through P2Y2 receptor stimulation in rabbit conjunctiva. Ophthalmic Res 2004; 36: 89\u201393.","journal-title":"Ophthalmic Res"},{"key":"BFeye2015125_CR25","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1136\/bjo.79.11.1007","volume":"79","author":"S Shimmura","year":"1995","unstructured":"Shimmura S, Ono M, Shinozaki K, Toda I, Takamura E, Mashima Y et al. Sodium hyaluronate in the treatment of dry eyes. Br J Ophthalmol 1995; 79: 1007\u20131011.","journal-title":"Br J Ophthalmol"},{"key":"BFeye2015125_CR26","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1136\/bjo.81.7.533","volume":"81","author":"N Yokoi","year":"1997","unstructured":"Yokoi N, Komuro A, Nishida K, Kinoshita S . Effectiveness of hyaluronan on corneal epithelial barrier function in dry eye. Br J Ophthalmol 1997; 81: 533\u2013536.","journal-title":"Br J Ophthalmol"},{"key":"BFeye2015125_CR27","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/art.1780290501","volume":"29","author":"RI Fox","year":"1986","unstructured":"Fox RI, Robinson CA, Curd JG, Kozin F, Howell FV . Sj\u00f6gren\u2019s syndrome. Proposed criteria for classification. Arthritis Rheum 1986; 29: 577\u2013583.","journal-title":"Arthritis Rheum"},{"key":"BFeye2015125_CR28","first-page":"181","volume":"24","author":"J Shimazaki","year":"2007","unstructured":"Shimazaki J . Definition and diagnosis of dry eye 2006. J Eye 2007; 24: 181\u2013184.","journal-title":"J Eye"},{"key":"BFeye2015125_CR29","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1755-3768.1993.tb07146.x","volume":"71","author":"I Toda","year":"1993","unstructured":"Toda I, Fujishima H, Tsubota K . Ocular fatigue is the major symptom of dry eye. Acta Ophthalmol (Copenh) 1993; 71: 347\u2013352.","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"BFeye2015125_CR30","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1097\/00003226-200005001-00008","volume":"19","author":"N Yokoi","year":"2000","unstructured":"Yokoi N, Bron AJ, Tiffany JM, Kinoshita S . Reflective meniscometry: A new field of dry eye assessment. Cornea 2000; 19: S37\u2013S43.","journal-title":"Cornea"},{"key":"BFeye2015125_CR31","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/00003226-200007000-00019","volume":"19","author":"H Oguz","year":"2000","unstructured":"Oguz H, Yokoi N, Kinoshita S . The height and radius of the tear meniscus and methods for examining these parameters. Cornea 2000; 19: 497\u2013500.","journal-title":"Cornea"},{"key":"BFeye2015125_CR32","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1001\/archopht.122.9.1265","volume":"122","author":"N Yokoi","year":"2004","unstructured":"Yokoi N, Bron AJ, Tiffany JM, Maruyama K, Komuro A, Kinoshita S . Relationship between tear volume and tear meniscus curvature. Arch Ophthalmol 2004; 122: 1265\u20131269.","journal-title":"Arch Ophthalmol"},{"key":"BFeye2015125_CR33","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.exer.2003.09.020","volume":"78","author":"N Yokoi","year":"2004","unstructured":"Yokoi N, Komuro A . A Non-invasive methods of assessing the tear film. Exp Eye Res 2004; 78: 399\u2013407.","journal-title":"Exp Eye Res"},{"key":"BFeye2015125_CR34","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/00061198-200312000-00008","volume":"12","author":"T Ishibashi","year":"2003","unstructured":"Ishibashi T, Yokoi N, Kinoshita S . Comparison of the short-term effects on the human corneal surface of topical timolol maleate with and without benzalkonium chloride. J Glaucoma 2003; 12: 486\u2013490.","journal-title":"J Glaucoma"},{"key":"BFeye2015125_CR35","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0002-9394(03)00317-9","volume":"136","author":"S Koh","year":"2003","unstructured":"Koh S, Watanabe H, Hosohata J, Hori Y, Hibino S, Nishida K et al. Diagnosing dry eye using a blue-free barrier filter. Am J Ophthalmol 2003; 136: 513\u2013519.","journal-title":"Am J Ophthalmol"},{"key":"BFeye2015125_CR36","first-page":"221","volume":"21","author":"MA Lemp","year":"1995","unstructured":"Lemp MA . Report of National Eye Institute\/Industry Work shop on clinical trials in dry eyes. CLAO J 1995; 21: 221\u2013232.","journal-title":"CLAO J"},{"key":"BFeye2015125_CR37","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1001\/archopht.1969.00990020012003","volume":"82","author":"OP van Bijsterveld","year":"1969","unstructured":"van Bijsterveld OP . Diagnostic tests in the sicca syndrome. Arch Ophthalmol 1969; 82: 10\u201314.","journal-title":"Arch Ophthalmol"},{"key":"BFeye2015125_CR38","doi-asserted-by":"publisher","first-page":"96","DOI":"10.2217\/ebo.12.340","volume-title":"Dry Eye Syndrome: Basic and Clinical Perspectives","author":"N Yokoi","year":"2013","unstructured":"Yokoi N, Georgiev GA . Tear-film-oriented diagnosis and therapy for dry eye Yokoi N Dry Eye Syndrome: Basic and Clinical Perspectives. Future Medicine: London, 2013; 96\u2013108."},{"key":"BFeye2015125_CR39","first-page":"719","volume":"107","author":"Y Hirotani","year":"2003","unstructured":"Hirotani Y, Yokoi N, Tsuzuki H, Kinoshita S . [Comparison of corneal and conjunctival rose bengal staining before and after punctal occlusion]. Nihon Ganka Gakkai Zasshi 2003; 107: 719\u2013723.","journal-title":"Nihon Ganka Gakkai Zasshi"},{"key":"BFeye2015125_CR40","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/978-1-4615-2417-5_90","volume":"350","author":"E Takamura","year":"1994","unstructured":"Takamura E, Takano H, Yoshino K, Negoro K, Tsubota K, Kobayashi T . Quantitative cellular evaluation of conjunctival squamous metaplasia in the dry eye patient. Adv Exp Med Biol 1994; 350: 535\u2013538.","journal-title":"Adv Exp Med Biol"},{"key":"BFeye2015125_CR41","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/978-1-4615-5359-5_75","volume":"438","author":"DT Jones","year":"1998","unstructured":"Jones DT, Monroy D, Ji Z, Pflugfelder SC . Alterations of ocular surface gene expression in Sj\u00f6gren's syndrome. Adv Exp Med Biol 1998; 438: 533\u2013536.","journal-title":"Adv Exp Med Biol"},{"key":"BFeye2015125_CR42","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S0161-6420(90)32478-8","volume":"97","author":"SC Pflugfelder","year":"1990","unstructured":"Pflugfelder SC, Huang AJW, Feuer W, Chuchovski PT, Pereira IC, Tseng SCG . Conjunctival cytologic features of primary Sj\u00f6gren's syndrome. Ophthalmology 1990; 97: 985\u2013991.","journal-title":"Ophthalmology"},{"key":"BFeye2015125_CR43","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/S0161-6420(95)31024-X","volume":"102","author":"I Toda","year":"1995","unstructured":"Toda I, Shimazaki J, Tsubota K . Dry eye with only decreased tear break-up time is sometimes associated with allergic conjunctivitis. Ophthalmology 1995; 102: 302\u2013309.","journal-title":"Ophthalmology"},{"key":"BFeye2015125_CR44","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1097\/ICO.0b013e3182930b1d","volume":"32","author":"S Shimazaki-Den","year":"2013","unstructured":"Shimazaki-Den S, Iseda H, Dogru M, Shimazaki J . Effects of diquafosol sodium eye drops on tear film stability in short BUT type of dry eye. Cornea 2013; 32: 1120\u20131125.","journal-title":"Cornea"},{"key":"BFeye2015125_CR45","first-page":"249","volume":"30","author":"Q Masuda","year":"2013","unstructured":"Masuda Q, Mori Y, Nejima R, Maruyama Y, Minami K, Miyata K . Efficacy of long-term treatment with diquafosol sodium for dry eye due to laser in situ keratomileusis. J Eye 2013; 30: 249\u2013253.","journal-title":"J Eye"},{"key":"BFeye2015125_CR46","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.ajo.2013.11.017","volume":"157","author":"I Toda","year":"2014","unstructured":"Toda I, Ide T, Fukumoto T, Ichihashi Y, Tsubota K . Combination Therapy with diquafosol tetrasodium and sodium hyaluronate in patients with dry eye after laser in situ keratomileusis. Am J Ophthalmol 2014; 157: 616\u2013622.","journal-title":"Am J Ophthalmol"},{"key":"BFeye2015125_CR47","first-page":"327","volume":"67","author":"T Takeshita","year":"2013","unstructured":"Takeshita T . Effect of diquafosol sodium ophthalmic solution for dry eye after cataract surgery. Jpn J Clin Ophthalmol 2013; 67: 327\u2013330.","journal-title":"Jpn J Clin Ophthalmol"},{"key":"BFeye2015125_CR48","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1136\/bjophthalmol-2012-302668","volume":"97","author":"R Arita","year":"2013","unstructured":"Arita R, Suehiro J, Haraguchi T, Maeda S, Maeda K, Tokoro H et al. Topical diquafosol for patients with obstructive meibomian gland dysfunction. Br J Ophthalmol 2013; 97: 725\u2013729.","journal-title":"Br J Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/eye2015125.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2015125","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2015125.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:25:00Z","timestamp":1684430700000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye2015125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,10]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["BFeye2015125"],"URL":"https:\/\/doi.org\/10.1038\/eye.2015.125","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,10]]},"assertion":[{"value":"16 December 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"NY is a consultant for Kissei Co., Ltd., Nagano, Japan and Rohto Co., Ltd, Osaka, Japan. SK is a consultant for Santen Pharmaceutical Co., Ltd, Osaka, Japan and Otsuka Pharmaceutical Co., Ltd., Tokyo, Japan. The remaining authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}